PANews reported on September 25th that according to Globenewswire, Scilex Holding Company (NASDAQ: SCLX), an innovative revenue-generating company, announced that it has completed its previously disclosed transaction pursuant to a Securities Purchase Agreement with an institutional investor, exchanging $200 million worth of common stock in its majority-owned subsidiary, Semnur Pharmaceuticals, Inc., for $200 million worth of Bitcoin. Scilex has now received the $200 million in Bitcoin into its crypto account.
Scilex, a publicly listed company, has completed a transaction to exchange shares for $200 million worth of Bitcoin.
Share to:
Author: PA一线
This content is for informational purposes only and does not constitute investment advice.
Follow PANews official accounts, navigate bull and bear markets together
Recommended Reading
